Encephalopsin inhibitors are a class of chemical compounds that specifically target and modulate the activity of encephalopsin, a photoreceptive protein found in the mammalian brain. Encephalopsin, also known as OPN3 (Opsin 3), is a member of the opsin family of proteins, which are typically associated with the visual system in the eyes. However, encephalopsin is unique in that it is primarily expressed in various regions of the brain, including the hypothalamus and the habenula, rather than in the photoreceptor cells of the retina. This distinct localization suggests that encephalopsin may play a crucial role in non-visual light sensing and circadian rhythm regulation within the central nervous system.
Encephalopsin inhibitors are designed to interfere with the activation or signaling pathways associated with encephalopsin, ultimately influencing its downstream effects on circadian rhythms and other physiological processes. By targeting encephalopsin, researchers aim to gain a deeper understanding of the intricate mechanisms governing the body's response to light cues and their impact on various neurobiological functions. These inhibitors can serve as valuable tools in both basic neuroscience research and applications in fields such as chronobiology, sleep regulation, and the study of mood disorders, offering insights into the intricate interplay between light perception, neural circuits, and the body's internal clock.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ritanserin | 87051-43-2 | sc-203681 sc-203681A | 10 mg 50 mg | $87.00 $306.00 | 2 | |
As a serotonin antagonist, it can interfere with serotonin pathways that may indirectly modulate OPN3 activity. | ||||||
Ketanserin | 74050-98-9 | sc-279249 | 1 g | $700.00 | ||
Antagonizes serotonin receptors, possibly altering serotonergic pathways that influence OPN3 activity. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A | 50 mg 500 mg | $68.00 $357.00 | 11 | |
Acts on multiple neurotransmitter pathways, including serotonergic systems, which could alter OPN3 signaling. | ||||||
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $80.00 $326.00 | 1 | |
As a selective 5-HT3 receptor antagonist, it affects serotonin signaling, which may have downstream effects on OPN3. | ||||||
Spiperone | 749-02-0 | sc-471047 | 250 mg | $130.00 | ||
A dopamine and serotonin antagonist, which may have an indirect effect on OPN3 signaling through these pathways. | ||||||
Pindolol | 13523-86-9 | sc-204847 sc-204847A | 100 mg 1 g | $194.00 $760.00 | ||
Has affinity for serotonin receptors and could indirectly modulate serotonergic signaling pathways linked to OPN3. | ||||||